Literature DB >> 34550574

The Current Status of Drug Discovery for the Oxytocin Receptor.

Philippe E Nashar1, Aidan A Whitfield1, Jiri Mikusek1, Tristan A Reekie2.   

Abstract

The oxytocin receptor plays a significant role in peripheral regulation of parturition and lactation. Given this important role, multiple drug discovery programs have been conducted to develop agonists and antagonists for peripheral activity. The role of the oxytocin receptor in the central nervous system is also significant, promoting social interaction, trust, and empathy in humans. As such, molecules that can access the central nervous system and target the oxytocin receptor are of significant interest. Due to the role of the oxytocin receptor in regulating social function and psychological well-being, agonists of this receptor have considerable promise for the treatment of numerous neuropsychiatric conditions. The poor pharmacokinetic properties and blood-brain barrier penetration of peptide-based molecules means nonpeptide compounds have more commonly been the focus for central nervous system activity. This chapter aims to summarize the current standing of peptide and nonpeptide drug discovery for antagonists and agonists of the oxytocin receptor and focusses on centrally active nonpeptidic agonists.
© 2022. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Agonist; Antagonist; Oxytocin; Oxytocin receptor; Peptide; Small molecule; Vasopressin

Mesh:

Substances:

Year:  2022        PMID: 34550574     DOI: 10.1007/978-1-0716-1759-5_10

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  89 in total

Review 1.  The oxytocin receptor system: structure, function, and regulation.

Authors:  G Gimpl; F Fahrenholz
Journal:  Physiol Rev       Date:  2001-04       Impact factor: 37.312

Review 2.  Social functioning in major depressive disorder.

Authors:  Aleksandra Kupferberg; Lucy Bicks; Gregor Hasler
Journal:  Neurosci Biobehav Rev       Date:  2016-07-06       Impact factor: 8.989

Review 3.  Neuropeptide receptor ligands as drugs for psychiatric diseases: the end of the beginning?

Authors:  Guy Griebel; Florian Holsboer
Journal:  Nat Rev Drug Discov       Date:  2012-05-18       Impact factor: 84.694

4.  Early Social-Emotional Functioning and Public Health: The Relationship Between Kindergarten Social Competence and Future Wellness.

Authors:  Damon E Jones; Mark Greenberg; Max Crowley
Journal:  Am J Public Health       Date:  2015-07-16       Impact factor: 9.308

Review 5.  The serotonin transporter gene and effectiveness of SSRIs.

Authors:  Alessandro Serretti; Masaki Kato
Journal:  Expert Rev Neurother       Date:  2008-01       Impact factor: 4.618

6.  Anxiety and depression: comorbidity, psychopathology, and social functioning.

Authors:  H Hecht; D von Zerssen; C Krieg; J Pössl; H U Wittchen
Journal:  Compr Psychiatry       Date:  1989 Sep-Oct       Impact factor: 3.735

Review 7.  Social neuroscience in psychiatry: unravelling the neural mechanisms of social dysfunction.

Authors:  A K J Fett; S S Shergill; L Krabbendam
Journal:  Psychol Med       Date:  2014-10-22       Impact factor: 7.723

Review 8.  Oxytocin and vasopressin agonists and antagonists as research tools and potential therapeutics.

Authors:  M Manning; A Misicka; A Olma; K Bankowski; S Stoev; B Chini; T Durroux; B Mouillac; M Corbani; G Guillon
Journal:  J Neuroendocrinol       Date:  2012-04       Impact factor: 3.627

9.  Social Functioning in Schizophrenia Clinical Correlations.

Authors:  M M Duțescu; R E Popescu; L Balcu; L C Duica; L M Strunoiu; D O Alexandru; M C Pîrlog
Journal:  Curr Health Sci J       Date:  2018-03-27

10.  Pharmacological treatments prescribed to people with autism spectrum disorder (ASD) in primary health care.

Authors:  Macey L Murray; Yingfen Hsia; Karen Glaser; Emily Simonoff; Declan G M Murphy; Philip J Asherson; Hanna Eklund; Ian C K Wong
Journal:  Psychopharmacology (Berl)       Date:  2013-05-17       Impact factor: 4.530

View more
  1 in total

1.  Structural basis for the activation and ligand recognition of the human oxytocin receptor.

Authors:  Janosch Ehrenmann; Santiago Vacca; Cristian Thom; Yann Waltenspühl; Ohad Medalia; Andreas Plückthun
Journal:  Nat Commun       Date:  2022-07-18       Impact factor: 17.694

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.